DK0781341T3 - Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler - Google Patents

Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler

Info

Publication number
DK0781341T3
DK0781341T3 DK95931242T DK95931242T DK0781341T3 DK 0781341 T3 DK0781341 T3 DK 0781341T3 DK 95931242 T DK95931242 T DK 95931242T DK 95931242 T DK95931242 T DK 95931242T DK 0781341 T3 DK0781341 T3 DK 0781341T3
Authority
DK
Denmark
Prior art keywords
plasmids
pct
preparation
recombinant proteins
modified cells
Prior art date
Application number
DK95931242T
Other languages
English (en)
Inventor
Beatrice Cameron
Joeel Crouzet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0781341T3 publication Critical patent/DK0781341T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • C07K14/501Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/68Stabilisation of the vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK95931242T 1994-09-16 1995-09-14 Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler DK0781341T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9411049A FR2724665B1 (fr) 1994-09-16 1994-09-16 Procede de production de proteines recombinantes, plasmides et cellules modifiees
PCT/FR1995/001178 WO1996008572A1 (fr) 1994-09-16 1995-09-14 Procede de production de proteines recombinantes, plasmides et cellules modifiees

Publications (1)

Publication Number Publication Date
DK0781341T3 true DK0781341T3 (da) 2009-01-05

Family

ID=9466987

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95931242T DK0781341T3 (da) 1994-09-16 1995-09-14 Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler

Country Status (19)

Country Link
US (1) US6143518A (da)
EP (1) EP0781341B1 (da)
JP (1) JP3696247B2 (da)
KR (1) KR100391752B1 (da)
AT (1) ATE405656T1 (da)
AU (1) AU708080B2 (da)
CA (1) CA2197804C (da)
DE (1) DE69535815D1 (da)
DK (1) DK0781341T3 (da)
ES (1) ES2313721T3 (da)
FI (1) FI120238B (da)
FR (1) FR2724665B1 (da)
IL (1) IL115308A (da)
MX (1) MX9701614A (da)
NO (1) NO320374B1 (da)
PT (1) PT781341E (da)
TW (1) TW517086B (da)
WO (1) WO1996008572A1 (da)
ZA (1) ZA957750B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618001D0 (en) * 1996-08-29 1996-10-09 Nyfotek As Novel expression vectors
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
EP1022337B1 (en) * 1999-01-20 2006-07-26 Bayer HealthCare AG Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
DE69929638T2 (de) 1999-01-20 2006-09-21 Bayer Healthcare Ag Plasmide, deren Konstruktion und Anwendung zur Herstellung von Interleukin-4 und dessen Muteine
CN1267551C (zh) * 1999-10-19 2006-08-02 印度生物技术国际有限公司 重组成熟溶葡萄球菌素的表达
WO2007049716A1 (ja) * 2005-10-27 2007-05-03 Kaneka Corporation 新規プラスミドベクター及びプラスミドを安定に保持する形質転換体
US9051589B2 (en) * 2005-10-27 2015-06-09 Kaneka Corporation Plasmid vector and transformant stably retaining plasmid
EP2303308A4 (en) 2008-05-13 2012-11-07 Clarassance Inc HUMAN RECOMBINANT PROTEIN CC10 AND COMPOSITIONS CONTAINING IT FOR THE TREATMENT OF NASAL RHINITIS
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
NZ599511A (en) 2009-10-15 2014-06-27 Clarassance Inc Recombinant human cc10 protein for treatment of influenza
BR102014014502B1 (pt) * 2014-06-13 2020-09-15 Ouro Fino Saúde Animal Ltda Vetor de expressão

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
NZ220917A (en) * 1986-07-11 1991-05-28 Merck & Co Inc Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
FR2642086B1 (fr) * 1989-01-26 1992-09-04 Sanofi Sa Gene recombinant codant pour un facteur basique de croissance des fibroblastes et ledit facteur
EP0406738A3 (en) * 1989-07-03 1991-08-14 Takeda Chemical Industries, Ltd. Production of acidic fgf protein
FR2661188B1 (fr) * 1990-04-24 1994-07-22 Rhone Poulenc Sante Nouveaux vecteurs de clonage et/ou d'expression, procede de preparation et leur utilisation.

Also Published As

Publication number Publication date
IL115308A0 (en) 1995-12-31
FI971100A (fi) 1997-03-14
US6143518A (en) 2000-11-07
TW517086B (en) 2003-01-11
NO971139D0 (no) 1997-03-12
JP3696247B2 (ja) 2005-09-14
FR2724665B1 (fr) 1996-12-20
AU708080B2 (en) 1999-07-29
FR2724665A1 (fr) 1996-03-22
MX9701614A (es) 1997-06-28
EP0781341A1 (fr) 1997-07-02
DE69535815D1 (de) 2008-10-02
PT781341E (pt) 2008-11-20
FI120238B (fi) 2009-08-14
CA2197804A1 (fr) 1996-03-21
FI971100A0 (fi) 1997-03-14
JPH10505746A (ja) 1998-06-09
ATE405656T1 (de) 2008-09-15
NO971139L (no) 1997-03-12
AU3475495A (en) 1996-03-29
CA2197804C (fr) 2010-11-16
ZA957750B (en) 1996-04-24
WO1996008572A1 (fr) 1996-03-21
EP0781341B1 (fr) 2008-08-20
KR100391752B1 (ko) 2003-10-22
IL115308A (en) 2009-07-20
ES2313721T3 (es) 2009-03-01
NO320374B1 (no) 2005-11-28

Similar Documents

Publication Publication Date Title
DK0575443T3 (da) Ærteproteinhydrolysat, fremgangsmåde til dets fremstilling og anvendelse deraf
DE50013610D1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
FI950628A0 (fi) Modifioidut sienisolut ja menetelmä rekombinanttituotteiden tuottamiseksi
DE69323879T2 (de) Herstellung von rekombinanten, menschlichem lactoferrin
DK1645631T3 (da) Neisseria antigener og præparater
DK0781341T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
HU9200548D0 (en) Improved activity process of recombined proteins
DK0851926T3 (da) Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
DK1025237T3 (da) Human kontrolpunktskinase, hCDS1, præparater og fremgangsmåder
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
NO971621L (no) Keratinocyttvekstfaktoranaloger
EP0546087A4 (da)
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
ES2114555T3 (es) Nuevo interferon gamma humano recombinado.
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
AU637589B2 (en) Ancrod proteins, their production and use